Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB26FX1JR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $65,000
Award facts
- Contract value 100% obligated
- $64,999.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On October 8, 2025, the Defense Logistics Agency awarded a delivery order valued at $65,000 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for Stelara 90 mg/ml syringes, with an ultimate completion date of October 30, 2025. This award utilizes firm fixed-price pricing and carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its small business status. The contract is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million and valid through November 2026, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare requirements.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription medications, biologics, and medical consumables to military health facilities nationwide. Stelara, an immunosuppressant biologic medication, represents one of many specialty pharmaceutical products the company delivers through its established relationship with the Defense Logistics Agency. The company's robust federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements, ranging from contraceptive devices to oncology treatments and specialty injections, making it a dependable partner for supporting the medical supply needs of Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FX1JR?
SPE2DB26FX1JR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 8, 2025.
How much is contract SPE2DB26FX1JR worth?
The government has obligated $65,000 on SPE2DB26FX1JR.
Is contract SPE2DB26FX1JR an order under another contract?
Yes. SPE2DB26FX1JR is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1JR competed?
The extent of competition for SPE2DB26FX1JR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award